Results 211 to 220 of about 152,507 (240)

Disrupting Viral Persistence: CRISPR/Cas9-Based Strategies for Hepatitis B and C Treatment, and Challenges. [PDF]

J Cell Mol Med
Li MF, Zubair A, Wdidi S, He S.
europepmc   +1 more source

Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain. [PDF]

Sci Rep
Popović J, Hahut A, Torres GE, Vincent A, Soto-Echevarria N, Wray B, Bartom ET, Paunesku T, Goodman CR, Woloschak GE.   +9 more
europepmc   +1 more source

Correction to 'Precise homology-directed installation of large genomic edits in human cells with cleaving and nicking high-specificity Cas9 variants'. [PDF]

Nucleic Acids Res
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CRISPR/Cas9

2023
CRISPR/Cas9 is the genome-editing technology that is most widely used around the world. Its widespread adoption is largely due to its simplicity and ease of use. Here, we introduce the construction of vectors and genome editing of the target gene in cells using the CRISPR/Cas9 system.
Izuho, Hatada, Sumiyo, Morita, Takuro, Horii   +2 more
openaire   +3 more sources

CRISPR/Cas9

2021
: ( ) - ( ).
Parul Sharma, Rajnish Sharma
openaire   +2 more sources

CRISPR/Cas9

2017
CRISPR/Cas9 is a novel method that has become the most widely used genome editing technology around the world. Its widespread adoption is largely due to its simplicity and easy of use. Here, we introduce the construction of vectors and genome editing of the target gene in cells expressing the CRISPR/Cas9 system.
Izuho, Hatada, Takuro, Horii
openaire   +3 more sources

Cas9 gets a classmate

Nature Biotechnology, 2015
Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.
Erik J, Sontheimer, Scot A, Wolfe
openaire   +2 more sources